Global flow cytometry market is estimated to be valued at USD 7.52 Bn in 2024 and is expected to exhibit a CAGR of 10.8% during the forecast period (2024-2031). The global flow cytometry market has been witnessing steady growth over the past few years due to the increasing applications of flow cytometry in research, clinical diagnostics, and treatment monitoring. Flow cytometry is a powerful laser-based technology used for analyzing the physiometric and biochemical characteristics of cells/particles as they flow in a fluid stream through a beam of light. Through staining with fluorescent probes and analysis on the basis of light scattering and fluorescence emission, flow cytometry allows examining the physical and chemical characteristics of cells and particles on a single-cell basis. Advancements in flow cytometry instruments, reagents, and software have enabled analyzing complex multicolor applications with high speed and accuracy. The growing proteomics and stem cell research along with increasing focus on personalized medicine are some of the key factors driving the demand for flow cytometry worldwide.

Market Dynamics:

The global flow cytometry market is driven by factors such as increasing research activity in the fields of immunology and hematology, growing stem cell research funding, rising prevalence of HIV/AIDS and cancer worldwide, and technological advancements in flow cytometry instruments. However, high cost of flow cytometry products is a major restraint for the market. Meanwhile, emerging markets such as Asia Pacific and Latin America provide significant growth opportunities for market players. Growing focus on personalized medicine approaches also presents opportunity for use of flow cytometry in companion diagnostics. Adoption of fluorescence-activated cell sorting (FACS) for biomanufacturing and drug discovery is another key trend expected to propel the market growth during the forecast period.

Key Features of the Study:

• This report provides an in-depth analysis of the global flow cytometry market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global flow cytometry market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study includes Luminex Corporation, Thermo Fisher Scientific, Inc., BD, Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH., Sysmex Corporation, Agilent Technologies, Inc., Danaher, Enzo Life Sciences, Inc., Cytek Biosciences, Sartorius AG, BioLegend, Inc., Beckman Coulter, Inc., and FlowMetric.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global flow cytometry market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global flow cytometry market.

Detailed Segmentation-

• By Technology:
  • Cell Based
  • Bead Based
• By Product Type:
  • Analyzer
  • Sorter
  • Reagent & Consumables
• By End User:
  • Hospitals
  • Clinical Testing Laboratories
  • Research Laboratories
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa

Company Profiles:

• Luminex Corporation
• Thermo Fisher Scientific, Inc.
• BD
• Bio-Rad Laboratories, Inc.
• Miltenyi Biotec GmbH.
• Sysmex Corporation
• Agilent Technologies, Inc.
• Danaher
• Enzo Life Sciences, Inc.
• Cytek Biosciences
• Sartorius AG
• BioLegend, Inc.
• Beckman Coulter, Inc.
• FlowMetric